Dual inhibition of IL-17A and IL-17F in psoriatic disease
Psoriasis and psoriatic arthritis are chronic immune-mediated disorders with involvement of interleukin (IL)-17 cytokines in their pathogenesis. IL-17A has been considered to be the most biologically active, but IL-17F is also over-expressed in skin and synovial tissues of patients with these diseas...
Saved in:
Main Authors: | Helena Iznardo (Author), Lluís Puig (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Significance of IL-23 Regulating IL-17A and/or IL-17F Positive Th17 Cells in Chronic Periodontitis
by: Zhenhua Luo, et al.
Published: (2014) -
Heparanase contributes to psoriatic lesions through crosstalk with IL-17 pathway
by: Chengyao Zhu, et al.
Published: (2023) -
The Influence of Interleukin 17A and IL17F Polymorphisms on Chronic Periodontitis Disease in Brazilian Patients
by: Joana Maira Valentini Zacarias, et al.
Published: (2015) -
IL-17A in the Psoriatic Patients' Serum and Plaque Scales as Potential Marker of the Diseases Severity and Obesity
by: Anna Michalak-Stoma, et al.
Published: (2020) -
IL17A and IL17RA gene polymorphisms in Fanconi anemia
by: Rafael Zancan MOBILE, et al.
Published: (2023)